(Q33964701)

30 July 2017

Prognostic value of response after upfront therapy for acute GVHD (English)

1 reference

30 July 2017

1

R M Saliba

1 reference

30 July 2017

4

G Rondon

1 reference

30 July 2017

7

R E Champlin

1 reference

30 July 2017

8

A M Alousi

1 reference

30 July 2017

3

S Giralt

1 reference

30 July 2017

D R Couriel

2

1 reference

30 July 2017

G-J Okoroji

series ordinal

5

1 reference

30 July 2017

A Rashid

series ordinal

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

7 March 2011

1 reference

Bone Marrow Transplantation

30 July 2017

1 reference

30 July 2017

47

1 reference

30 July 2017

1

1 reference

30 July 2017

125-131

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2011.41

30 July 2017

0 references

cites work

Graft-versus-host disease treatment: predictors of survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

A phase III study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

Impact of graft-versus-host disease on survival

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

Pitfalls in the design of clinical trials for prevention or treatment of acute graft-versus-host disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

1994 Consensus Conference on Acute GVHD Grading

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

The best endpoint for acute GVHD treatment trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4114039

A new look at the statistical model identification

29 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBMT.2011.41

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/BMT.2011.41

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference